An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the one that causes COVID-19. The antibody, called S309, is now on a fast-track development and testing path at Vir Biotechnology in the next step toward possible clinical trials.
- Jurassic fossils from northeastern China reveal morphological stasis in the catkin-yew
- Columbia physicians give first comprehensive review of COVID-19’s effects outside the lung
- Couldn’t socially distance? Blame your working memory
- Theft law needs reform to reduce the risk of judgements which lack ‘common sense’
- Is what I see, what I imagine? Study finds neural overlap between vision and imagination